Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Transthyretin Amyloidosis Treatment Market 2025 – By Type (Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM), Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)), By Drug (Tafamidis, Patisiran, Inotersen, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2034

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Report Price : $4490.00 | Pages : 278 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Transthyretin Amyloidosis Treatment Market Definition

Transthyretin amyloidosis (ATTR) treatment refers to the medical treatments aimed at managing transthyretin amyloidosis, a progressive, life-threatening disease resulting from misfolded transthyretin proteins that form amyloid deposits in tissues. The condition arises due to familial or spontaneous mutations that destabilize transthyretin protein, causing aggregation and deposition of fibers in various tissues. This rare condition primarily affects the peripheral nerves, heart and other organs, with the two main forms being polyneuropathy (nerve damage) and cardiomyopathy (heart muscle disease).

The ATTR treatment market consists of sales by entities (organizations, sole traders and partnerships) of ATTR treatment drugs that are essential for controlling the disease's progression, managing symptoms and improving the quality of life for affected patients, as untreated cases can lead to significant morbidity and reduced life expectancy.

Book your 30 minutes free consultation with our research experts

Contact Us

Transthyretin Amyloidosis Treatment Market Size

The global transthyretin amyloidosis treatment market reached a value of nearly $4,250.83 million in 2023, having grown at a compound annual growth rate (CAGR) of 95.43% since 2018. The market is expected to grow from $4,250.83 million in 2023 to $6,289.03 million in 2028 at a rate of 8.15%. The market is then expected to grow at a CAGR of 8.91% from 2028 and reach $9,635.77 million in 2033.    

Growth in the historic period resulted from increased healthcare expenditure, increasing adoption of personalized medicine, enhanced healthcare infrastructure and increasing prevalence of transthyretin amyloidosis cases. Factor that negatively affected growth in the historic period was limited awareness.

Going forward, increasing aging population, increasing regulatory approvals, increasing e-commerce growth, strong economic growth in emerging markets and favorable government initiatives will drive the growth. Factor that could hinder the growth of the transthyretin amyloidosis treatment market in the future include high cost of treatment.  

Transthyretin Amyloidosis Treatment Market Drivers

The key drivers of the transthyretin amyloidosis treatment market include:

Increasing Aging Population

The increasing size of the aging population is expected to propel the growth of the transthyretin amyloidosis (ATTR) treatment market in the forecast period. The aging population is expected to undergo more frequent medical check-ups and diagnostic procedures, leading to a higher rate of ATTR detection and diagnosis. As awareness of the condition increases among both healthcare professionals and patients, the likelihood of earlier diagnosis rises, prompting a greater demand for treatment options. For instance, according to the United Nations Department of Economic and Social Affairs, a US-based intergovernmental agency, the global population of individuals aged 65 years or older is expected to increase dramatically, more than doubling from 761 million in 2021 to 1.6 billion by 2050. In 2021, one out of every ten individuals worldwide were 65 or older. By 2050, projections indicate that this age group will comprise one out of every six people globally.  Additionally, in October 2023, according to the United Nations Population Fund, a US-based agency aimed at improving reproductive and maternal health worldwide, the demographic of individuals aged 60 and above is expected to rise from 149 million in 2022 to 347 million by 2050. India's elderly population is forecast to double by 2050, surpassing the number of children in the country.  Therefore, the increasing aging population will drive the growth of the ATTR treatment market.

Transthyretin Amyloidosis Treatment Market Restraints

The key restraints on the transthyretin amyloidosis treatment market include:

High Cost of Treatment

High cost of treatment is expected to restrain the growth of the ATTR treatment market. The high cost of ATTR treatments imposes a significant financial strain on healthcare systems, especially in regions with publicly funded healthcare or limited budgets for rare diseases. This could lead to delayed access or restricted availability of treatments, thereby slowing market growth. Treatment for transthyretin amyloidosis involves a combination of medications, ongoing monitoring and sometimes hospitalization, making it quite complex and costly. For patients needing advanced therapies like tafamidis or diflunisal, the annual treatment expenses can exceed $100,000. Tafamidis, in particular, is known for its high price, which can reach around $225,000 per year, making it one of the most expensive cardiovascular drugs available.  Therefore, the high cost of treatment will limit the growth of the ATTR treatment market.

Transthyretin Amyloidosis Treatment Market Trends

Major trends shaping the transthyretin amyloidosis treatment market include:

Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody

Major companies operating in the transthyretin amyloidosis treatment market are advancing treatment options for amyloidosis with novel therapeutic antibodies. The objective is to address the treatment gap for the disease by offering essential therapies to patients with limited treatment options. For instance, in May 2024, AstraZeneca, a UK-based pharmaceutical company, through its Rare Disease subsidiary, Alexion, initiated research focused on cardiomyopathy associated with transthyretin amyloidosis (ATTR). This effort includes the launch of the Phase 3 DepleTTR-CM study for ALXN2220, an investigational antibody designed to target cardiac amyloid deposits—harmful protein buildups that can cause serious cardiac complications, including progressive heart failure if left untreated. By reducing these deposits, ALXN2220 aims to mitigate symptoms and slow the progression of ATTR cardiomyopathy, a severe condition that can greatly affect patients’ quality of life.  Additionally, in July 2021, Novo Nordisk is a Denmark-based pharmaceutical company acquired Prothena Corporation's clinical-stage antibody, PRX004, along with its broader program for the treatment of ATTR amyloidosis, a severe and rare disease marked by the accumulation of misfolded proteins in organs, particularly the heart, for $1.2 billion.  This acquisition is intended to strengthen Novo Nordisk's portfolio in innovative cardiovascular treatments by utilizing Prothena's amyloidosis expertise to address substantial unmet medical needs in this sector. Prothena Corporation is an Ireland-based company that provides treatment for transthyretin amyloidosis.

Opportunities And Recommendations In The Transthyretin Amyloidosis Treatment Market

Opportunities – The top opportunities in the transthyretin amyloidosis treatment market segmented by type will arise in the transthyretin amyloidosis with cardiomyopathy (ATTR-CM) segment, which will gain $1,566.37 million of global annual sales by 2028. The top opportunities in the transthyretin amyloidosis treatment market segmented by drug will arise in the tafamidis segment, which will gain $1,536.00 million of global annual sales by 2028. The top opportunities in the transthyretin amyloidosis treatment market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $1,545.80 million of global annual sales by 2028. The transthyretin amyloidosis treatment market size will gain the most in the USA at $679.70 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the transthyretin amyloidosis treatment companies to focus on advancing novel therapeutics for transthyretin amyloidosis, focus on ATTR-PN for market growth, focus on the other drugs segment for growth, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, focus on hospital pharmacies for market growth and  focus on aging population worldwide.

Transthyretin Amyloidosis Treatment Market Segmentation

The transthyretin amyloidosis treatment market is segmented by type, by drug and by distribution channels.

By Type –
The transthyretin amyloidosis treatment market is segmented by type into:
    • a) Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
    • b) Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)
The transthyretin amyloidosis with cardiomyopathy (ATTR-CM) market was the largest segment of the transthyretin amyloidosis treatment market segmented by type, accounting for 81.29% or $3,455.48 million of the total in 2023. Going forward, the transthyretin amyloidosis with polyneuropathy (ATTR-PN) segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by type, at a CAGR of 9.76% during 2023-2028.

By Drug –
The transthyretin amyloidosis treatment market is segmented by drug into:
    • a) Tafamidis
    • b) Patisiran
    • c) Inotersen
    • d) Other Drugs
The tafamidis market was the largest segment of the transthyretin amyloidosis treatment market segmented by drug, accounting for 80.82% or $3,435.49 million of the total in 2023. Going forward, the other drugs segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by drug, at a CAGR of 11.69% during 2023-2028.

By Distribution Channel –
The transthyretin amyloidosis treatment market is segmented by distribution channel into:
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Online Pharmacies
The hospital pharmacies market was the largest segment of the transthyretin amyloidosis treatment market segmented by distribution channel, accounting for 77.47% or $3,293.31 million of the total in 2023. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the transthyretin amyloidosis treatment market segmented by distribution channel, at a CAGR of 9.39% during 2023-2028.

By Geography - The transthyretin amyloidosis treatment market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the transthyretin amyloidosis treatment market, accounting for 55.89% or $2,375.65 million of the total in 2023. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the transthyretin amyloidosis treatment market will be South America and Middle East where growth will be at CAGRs of 55.78% and 49.14% respectively. These will be followed by Africa and Asia Pacific where the markets are expected to grow at CAGRs of 36.26% and 20.52% respectively.

Transthyretin Amyloidosis Treatment Market Competitive Landscape

Major Competitors are:

  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc.
  • BridgeBio Pharma, Inc.
  • Intellia Therapeutics Inc.

    • Other Competitors Include:

  • AstraZeneca
  • Novo Nordisk A/S
  • PTC Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • Abbvie Inc.
  • SOM Biotech
  • Prothena Biosciences
  • AstraZeneca
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Takeda Pharmaceuticals
  • ONPATTRO
  • Asprius Lifesciences
  • Alexion Pharmaceuticals
  • Prothena Corporation
  • Sanofi
  • Bayer
  • Chiesi Farmaceutici
  • Regeneron Pharmaceuticals
  • MedLife S.A.
  • Pharmstandard
  • Generium
  • Attralus, Inc
  • Ionis Pharmaceuticals
  • Sorrento Therapeutics Inc.
  • Ionis Pharmaceuticals
  • GSK South Africa

      • Table Of Contents

      1 Executive Summary

      1.1 Transthyretin Amyloidosis Treatment – Market Attractiveness And Macro Economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Transthyretin Amyloidosis Treatment Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Transthyretin Amyloidosis With Polyneuropathy

      6.4.2 Transthyretin Amyloidosis With Cardiomyopathy

      6.5 Market Segmentation By Drug

      6.5.1 Tafamidis

      6.5.2 Patisiran

      6.5.3 Inotersen

      6.5.4 Other Drugs

      6.6 Market Segmentation By Distribution Channel

      6.6.1 Hospital Pharmacies

      6.6.2 Retail Pharmacies

      6.6.3 Online Pharmacies

      7 Major Market Trends

      7.1 Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody

      8 Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Transthyretin Amyloidosis Treatment Market

      8.2 Impact Of The War In Ukraine On The Transthyretin Amyloidosis Treatment Market

      8.3 Impact Of High Inflation On The Transthyretin Amyloidosis Treatment Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Transthyretin Amyloidosis Treatment Market Segmentation

      10.1 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Transthyretin Amyloidosis Treatment Market, Regional and Country Analysis

      11.1 Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.2 Market Overview

      12.2.1 Region Information

      12.2.2 Market Information

      12.2.3 Background Information

      12.2.4 Government Initiatives

      12.2.5 Regulations

      12.2.6 Regulatory Bodies

      12.2.7 Major Associations

      12.2.8 Taxes Levied

      12.2.9 Corporate Tax Structure

      12.2.10 Investments

      12.2.11 Major Companies

      12.3 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.6 China Market

      12.7 Summary

      12.8 Market Overview

      12.8.1 Country Information

      12.8.2 Market Information

      12.8.3 Background Information

      12.8.4 Government Initiatives

      12.8.5 Regulations

      12.8.6 Regulatory Bodies

      12.8.7 Major Associations

      12.8.8 Taxes Levied

      12.8.9 Corporate Tax Structure

      12.8.10 Major Companies

      12.9 China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.12 India Market

      12.13 India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.16 Japan Market

      12.17 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.20 Australia Market

      12.21 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.24 Indonesia Market

      12.25 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.28 South Korea Market

      12.29 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.31 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.2 Market Overview

      13.2.1 Region Information

      13.2.2 Market Information

      13.2.3 Background Information

      13.2.4 Government Initiatives

      13.2.5 Regulations

      13.2.6 Regulatory Bodies

      13.2.7 Major Associations

      13.2.8 Taxes Levied

      13.2.9 Corporate tax structure

      13.2.10 Investments

      13.2.11 Major Companies

      13.3 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.6 Western Europe Transthyretin Amyloidosis Treatment Market: Country Analysis

      13.7 UK Market

      13.8 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.11 Germany Market

      13.12 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.15 France Market

      13.16 France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.19 Italy Market

      13.20 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.23 Spain Market

      13.24 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.26 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.2 Market Overview

      14.2.1 Region Information

      14.2.2 Market Information

      14.2.3 Background Information

      14.2.4 Government Initiatives

      14.2.5 Regulations

      14.2.6 Regulatory Bodies

      14.2.7 Major Associations

      14.2.8 Taxes Levied

      14.2.9 Corporate Tax Structure

      14.2.10 Investments

      14.2.11 Major companies

      14.3 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.6 Eastern Europe Transthyretin Amyloidosis Treatment Market: Country Analysis

      14.7 Russia Market

      14.8 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.10 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.2 Market Overview

      15.2.1 Region Information

      15.2.2 Market Information

      15.2.3 Background Information

      15.2.4 Government Initiatives

      15.2.5 Regulations

      15.2.6 Regulatory Bodies

      15.2.7 Major Associations

      15.2.8 Taxes Levied

      15.2.9 Corporate Tax Structure

      15.2.10 Investments

      15.2.11 Major Companies

      15.3 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.6 North America Transthyretin Amyloidosis Treatment Market: Country Analysis

      15.7 USA Market

      15.8 Summary

      15.9 Market Overview

      15.9.1 Country Information

      15.9.2 Market Information

      15.9.3 Background Information

      15.9.4 Government Initiatives

      15.9.5 Regulations

      15.9.6 Regulatory Bodies

      15.9.7 Major Associations

      15.9.8 Taxes Levied

      15.9.9 Corporate Tax Structure

      15.9.10 Investments

      15.9.11 Major Companies

      15.10 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.12 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada Market

      15.14 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.15 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.16 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.2 Market Overview

      16.2.1 Region Information

      16.2.2 Market Information

      16.2.3 Background Information

      16.2.4 Government Initiatives

      16.2.5 Regulations

      16.2.6 Regulatory Bodies

      16.2.7 Major Associations

      16.2.8 Taxes Levied

      16.2.9 Corporate Tax Structure

      16.2.10 Investments

      16.2.11 Major Companies

      16.3 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.6 South America Transthyretin Amyloidosis Treatment Market: Country Analysis

      16.7 Brazil Market

      16.8 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.10 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.2 Market Overview

      17.2.1 Region Information

      17.2.2 Market Information

      17.2.3 Background Information

      17.2.4 Government Initiatives

      17.2.5 Regulations

      17.2.6 Regulatory Bodies

      17.2.7 Major Associations

      17.2.8 Taxes Levied

      17.2.9 Corporate Tax Structure

      17.2.10 Major Companies

      17.3 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.5 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.2 Market Overview

      18.2.1 Region Information

      18.2.2 Market Information

      18.2.3 Background Information

      18.2.4 Government Initiatives

      18.2.5 Regulations

      18.2.6 Regulatory Bodies

      18.2.7 Major Associations

      18.2.8 Taxes Levied

      18.2.9 Major Companies

      18.3 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.5 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Pfizer Inc

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Alnylam Pharmaceuticals, Inc

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 Ionis Pharmaceuticals, Inc

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 BridgeBio Pharma, Inc

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.6 Intellia Therapeutics Inc

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      20 Other Major And Innovative Companies

      20.1 AstraZeneca

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Novo Nordisk A/S

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 PTC Therapeutics Inc.

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 Bristol-Myers Squibb Company

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Abbvie Inc.

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 SOM Biotech

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 Corino Therapeutics Inc.

      20.7.1 Company Overview

      20.7.2 1.7.2 Products And Services

      20.8 Acrotech Biopharma Inc.

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Neurimmune AG

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Sorrento Therapeutics, Inc.

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 Oncopeptides AB

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 Takeda Pharmaceutical Company Limited

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 Astellas Pharma, Inc.

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 GSK plc

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 Bausch Health Company

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Astellas Pharma Acquired Polyphor International

      23.2 AstraZeneca Acquired Caelum Biosciences

      23.3 Novo Nordisk Acquired Prothena Corporation

      24 Opportunities And Strategies

      24.1 Global Transthyretin Amyloidosis Treatment Market In 2028 – Countries Offering Most New Opportunities

      24.2 Global Transthyretin Amyloidosis Treatment Market In 2028 – Segments Offering Most New Opportunities

      24.3 Global Transthyretin Amyloidosis Treatment Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Transthyretin Amyloidosis Treatment Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Transthyretin Amyloidosis Treatment Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Transthyretin Amyloidosis Treatment Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 9:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 10: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 11: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: China GDP Per Capita, 2018-2023, $
    • Table 14:  China Population, 2018-2028, Millions
    • Table 15: China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 16: China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 34:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 35: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 36: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 54:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 55: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 56: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 62:  North America Population, By Country, 2018-2028, Millions
    • Table 63: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 64: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: USA GDP Per Capita, 2018-2023, $
    • Table 67:  USA Population, 2018-2028, Millions
    • Table 68: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 69: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 75:  South America Population, By Country, 2018-2028, Millions
    • Table 76: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 77: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 83:  Middle East Population, By Country, 2018-2028, Millions
    • Table 84: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 85: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 88:  Africa Population, By Country, 2018-2028, Millions
    • Table 89: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 90: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Global Transthyretin Amyloidosis Treatment Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 93: Pfizer Inc – Financial Overview, 2019 – 2023, $Billion
    • Table 94: Alnylam Pharmaceuticals Inc – Financial Overview, 2019 – 2023, $Billion
    • Table 95: Ionis Pharmaceuticals, Inc – Financial Overview, 2019 – 2023, $Billion
    • Table 96: Transthyretin Amyloidosis Treatment Market, Competitive Benchmarking (In USD Millions)
    • Table 97: Transthyretin Amyloidosis Treatment Market, Competitive Dashboard
    • Table 98: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 99: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028
    • Table 100: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Drug, 2023 – 2028
    • Table 101: Global Transthyretin Amyloidosis Treatment Market Size Gain ($ Million), Segmentation By Distribution Channel, 2023 – 2028
    • Table 102: Transthyretin Amyloidosis Treatment Market Data Sources

    List Of Figures

      Figure 1: Global Transthyretin Amyloidosis Treatment Market Segmentation By Type
    • Figure 2: Global Transthyretin Amyloidosis Treatment Market Segmentation By Drug
    • Figure 3: Global Transthyretin Amyloidosis Treatment Market Segmentation By Distribution Channel
    • Figure 4: Global Transthyretin Amyloidosis Treatment Market, Historic, 2018 – 2023, $ Million
    • Figure 5: Global Transthyretin Amyloidosis Treatment Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 6: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 7: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Global Transthyretin Amyloidosis Treatment Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 78: Pfizer Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 79: Alnylam Pharmaceuticals Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 80: Ionis Pharmaceuticals, Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 81: Geographic Regions Covered

    Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

    Read More

    How Will The Nuclear Medicine Market Grow In 2022?

    Read More

    What Is The Pediatric Imaging Market Overview In 2022?

    Read More

    Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

    Read More

    Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

    View Report

    Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

    View Report

    Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)

    View Report

    Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

    View Report

    Dental Services Market 2022 – By Type (General Dentistry, Oral Surgery, Orthodontics, Prosthodontics), By Type Of Procedure (Cosmetic Dentistry, Non-Cosmetic Dentistry), By End-User (Gender) (Male, Female), By Type Of Expenditure (Public, Private), And By Region, Opportunities And Strategies – Global Forecast To 2031 

    View Report

    Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Value Based Care Payment Global Market Report 2025 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer) – Market Size, Trends, And Global Forecast 2025-2034

    View Report

    Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2025-2034

    View Report